Smoothened activators are compounds that functionally upregulate the activity of the smoothened (SMO) protein, a G protein-coupled receptor (GPCR) that is a central component of the Hedgehog (Hh) signaling pathway. This signaling pathway is critical for embryonic development and is also involved in the regulation of stem cell proliferation and differentiation, as well as tissue homeostasis in adults. The Hh pathway is initiated when Hedgehog ligands bind to another protein called Patched (PTCH), relieving its inhibition on SMO, which in turn triggers a cascade of intracellular events leading to the activation of GLI transcription factors and subsequent gene expression.
Direct activators of SMO are molecules that bind to SMO itself, mimicking the derepression normally caused by Hedgehog ligand interaction with PTCH. These activators can bind to the heptahelical domain of SMO, inducing a conformational change that mimics the active state of the protein. As a result, the downstream signaling cascade is activated, leading to the transcription of target genes that are normally regulated by Hh signaling. Indirect activators of SMO might not interact with SMO directly but could potentiate its activity by other means. These might include the suppression of negative regulators of SMO or the upregulation of molecules that facilitate SMO's translocation to the primary cilium, a cellular structure where Hh pathway components accumulate and where SMO is activated. They could also enhance the production of endogenous molecules that facilitate SMO activation or increase the stability of SMO within cellular membranes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Smoothened Agonist, HCl | 364590-63-6 | sc-202814 sc-202814A | 1 mg 5 mg | $210.00 $520.00 | 31 | |
SAG is a smoothened (SMO) agonist that activates the Hedgehog signaling pathway, which includes SMO as a key component. SAG's activation of SMO leads to the activation of the downstream GLI transcription factors. | ||||||
Purmorphamine | 483367-10-8 | sc-202785 sc-202785A | 1 mg 5 mg | $57.00 $184.00 | 18 | |
Purmorphamine directly binds to and activates SMO. This activates the Hedgehog signaling pathway and ultimately leads to the activation of GLI transcription factors. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine is an antagonist of SMO but at a low concentration, it can have an agonistic effect. It can bind to and inhibit SMO, but when used at a lower concentration, it can indirectly activate SMO and stimulate the downstream Hedgehog signaling pathway. | ||||||
20α-Hydroxy Cholesterol | 516-72-3 | sc-209393 | 10 mg | $300.00 | ||
20(S)-Hydroxycholesterol is a natural SMO modulator that can bind to and activate SMO. This stimulates the Hedgehog signaling pathway and leads to the activation of downstream GLI transcription factors. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Itraconazole is primarily an antifungal drug that has been found to inhibit SMO but at a low concentration, it can have an agonistic effect. It can bind to and inhibit SMO, but when used at a lower concentration, it can indirectly activate SMO and stimulate the downstream Hedgehog signaling pathway. | ||||||
Tomatidine hydrochloride | 6192-62-7 | sc-200931 | 25 mg | $67.00 | 1 | |
Tomatidine is a steroidal alkaloid that can bind to and activate SMO. This stimulates the Hedgehog signaling pathway and leads to the activation of downstream GLI transcription factors. | ||||||
SANT-1 | 304909-07-7 | sc-203253 | 5 mg | $135.00 | 5 | |
SANT-1 is a SMO antagonist but at a low concentration, it can have an agonistic effect. By binding to and inhibiting SMO, it can indirectly activate SMO at lower concentrations, stimulating the downstream Hedgehog signaling pathway. | ||||||